BioCentury
ARTICLE | Product Development

What Moderna’s COVID-19 vaccine data does not say about protection

Parlays Phase I data for mRNA-1273 into $1.3 billion follow-on

May 19, 2020 1:49 AM UTC


Access this Article

BCIQ Company Profiles

Moderna Inc.